Clinical application of active aspiration fluid biopsy for pancreatic neoplasia diagnosis in oncology practice

Cover Page

Cite item

Full Text

Abstract

Introduction. Differential diagnosis of pancreatic cystic neoplasms (PCNs) presents a significant clinical challenge due to their structural heterogeneity. Pancreatic juice represents a highly specific biological medium of particular interest, containing both cellular components and potential molecular biomarkers. We present a novel technique — Active Duodenal Aspiration Biopsy (DAB) — enabling collection of pancreatic juice-bile mixtures for diagnostic analysis. Aim. To evaluate the efficacy of this original DAB technique when integrated with standard diagnostic modalities across different levels of oncology care institutions. Materials and Methods. Patients with inconclusive standard diagnostic workups underwent DAB procedures. Aspirates were analyzed cytologically and through carcinoembryonic antigen (CEA) level quantification. Results. In a case series of six patients with various pancreatic cystic neoplasms, DAB demonstrated feasibility and diagnostic utility when combined with conventional verification methods. CEA levels and cytological findings from DAB aspirates enabled precise diagnosis and informed treatment strategy modifications. Conclusion. This preliminary experience indicates DAB is both safe and effective. The technique is applicable across outpatient and inpatient oncology settings and shows potential for improving early pancreatic cancer detection.

About the authors

A. A. Kashintcev

Saint Petersburg State Pediatric Medical University; Pandx LLC

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-3708-1129
SPIN-code: 2585-1162
Scopus Author ID: 56352374500
ResearcherId: AAZ-4123–2021
St. Petersburg, the Russian Federation; St. Petersburg

N. Yu. Kokhanenko

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-8214-5312
SPIN-code: 5383-3214
Scopus Author ID: 42661448700
ResearcherId: A-9031-2014
St. Petersburg, the Russian Federation

K. V. Pavelets

Saint Petersburg State Pediatric Medical University; SPb SBIH “Mariinskyi hospital”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-1921-8427
SPIN-code: 402534
Scopus Author ID: 6506476558
ResearcherId: HPE-6537-2023
St. Petersburg, the Russian Federation; St. Petersburg

I. A. Soloviev

SPb SBIH “Mariinskyi hospital”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0001-9646-9775
SPIN-code: 6703-4852
Scopus Author ID: 57190217419
ResearcherId: O-5941-2017
St. Petersburg, the Russian Federation

D. S. Rusanov

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0001-9101-7673
SPIN-code: 1193-4108
Scopus Author ID: 57199159392
ResearcherId: GVU-6362-2022
St. Petersburg, the Russian Federation

O. G. Vavilova

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-4298-8171
SPIN-code: 2620-7115
Scopus Author ID: 37001441600
ResearcherId: H-2074-2015
St. Petersburg, the Russian Federation

Y. V. Radionov

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0003-3556-4247
SPIN-code: 1532-8871
Scopus Author ID: 56352567400
ResearcherId: AAV-3875-2020
St. Petersburg, the Russian Federation

M. S. Dinikin

SPb SBIH “City Clinical Oncology Dispensary”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0003-0272-4240
SPIN-code: 1371-1548
Scopus Author ID: 51161103900
ResearcherId: JJF-8869-2023
St. Petersburg, the Russian Federation

M. Yu. Agapov

SPb SBIH “City Clinical Oncology Dispensary”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-6322-6782
SPIN-code: 9360-2486
Scopus Author ID: 56563922600
ResearcherId: ABN-8737-2022
St. Petersburg, the Russian Federation

Y. V. Pelipas

SPb SBIH “City Clinical Oncology Dispensary”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0003-3647-0445
SPIN-code: 3549-5476
Scopus Author ID: 55907546800
ResearcherId: HDN-9156-2022
St. Petersburg, the Russian Federation

Y. A. Gulyaev

SPb SBIH “City Clinical Oncology Dispensary”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-8053-3952
SPIN-code: 7033-0629
Scopus Author ID: 7102364193
ResearcherId: HPE-6841-2023
St. Petersburg, the Russian Federation

T. Sh. Morgoshiia

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0003-3838-177X
SPIN-code: 5560-2570
Scopus Author ID: 57202005502
ResearcherId: ACM-4211-2022
St. Petersburg, the Russian Federation

F. A. Magomedova

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0009-0004-8514-3859
SPIN-code: 3216-3619
Scopus Author ID: 57217624428
St. Petersburg, the Russian Federation

L. A. Solovyova

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-7435-8326
SPIN-code: 3851-3715
Scopus Author ID: 57216509402
ResearcherId: E-6675-2014
St. Petersburg, the Russian Federation

A. A. Nadeeva

Pandx LLC

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0003-0872-9157
SPIN-code: 3816-3617
Scopus Author ID: 59391178700
ResearcherId: LZI-2019-2025
St. Petersburg, the Russian Federation

A. V. Borovikova

Saint Petersburg State Pediatric Medical University; SPb SBIH “Mariinskyi hospital”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0001-1706-2676
SPIN-code: 2959-1232
Scopus Author ID: 57189374258
ResearcherId: IDOEP:-0866-2025
St. Petersburg, the Russian Federation; St. Petersburg

K. V. Laptev

SPb SBIH “Mariinskyi hospital”

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0009-0001-2225-5894
SPIN-code: 598809
Scopus Author ID: 7006160613
ResearcherId: I-8159-2016
St. Petersburg, the Russian Federation

A. V. Lemeshev

Saint Petersburg State Pediatric Medical University

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0009-0003-5567-3851
SPIN-code: 7635-4548
Scopus Author ID: 6506457693
St. Petersburg, the Russian Federation

V. Yu. Proutski

Pandx LLC

Email: alexey.kashintsev@pandx.ru
ORCID iD: 0000-0002-2432-8698
SPIN-code: 168494
Scopus Author ID: 6603244592
St. Petersburg, the Russian Federation

References

  1. Cho J., Petrov M.S. Pancreatitis, pancreatic cancer, and their metabolic sequelae: Projected burden to 2050. Clinical and Translational Gastroenterology. 2020; 11(11): e00251.-DOI: https://doi.org/10.14309/ctg.0000000000000251.
  2. Cronin K.A., Scott S., Firth A.U., et al. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer. 2022; 128(24): 4251-4284.-DOI: https://doi.org/10.1002/cncr.34479.
  3. NCCN guidelines ver.1.2024. Pancreatic adenocarcinoma.-URL: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.
  4. Goggins M., Overbeek K.A., Brand R., et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020; 69(1): 7-17.-DOI: https://doi.org/10.1136/gutjnl-2019-319352.
  5. Ohtsuka T., Fernandez-Del Castillo C., Furukawa T., et al. International evidence-based Kyotoguidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024; 24(2): 255-270.-DOI: https://doi.org/10.1016/j.pan.2023.12.009.
  6. Zerboni G., Signoretti M., Crippa S., et al. Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology. 2019; 19(1): 2-9.-DOI: https://doi.org/10.1016/j.pan.2018.11.014.
  7. Terasawa H., Matsumoto K., Tanaka T., et al. Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications including needle tract seeding. Pancreatology. 2023; 23(8): 988-995.-DOI: https://doi.org/10.1016/j.pan.2023.10.018.
  8. Levink I.J.M., Visser I.J., Koopmann B.D.M., et al. Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. Gastrointest Endosc. 2022; 96(5): 801-813.e2.-DOI: https://doi.org/10.1016/j.gie.2022.04.1342.
  9. Sadakari Y., Kanda M., Maitani K., et al. Mutant KRAS and GNAS DNA concentrations in secretin-stimulated pancreatic fluid collected from the pancreatic duct and the duodenal lumen. Clin Transl Gastroenterol. 2014; 5: e62.-DOI: https://doi.org/10.1158/1078-0432.CCR-17-2463.
  10. Kashintsev A.A. inventor; PANDX LTD., assignee. Catheter and method for isolating a region in a hollow organ of a mammal, and system based on the catheter, and use of the catheter. Patent WO2021137739. 2021; Oct 28.-URL: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021137739&_cid=P10-LRRSSJ-50103-1.
  11. Заитова Я.О., Кашинцев А.А., Коханенко Н.Ю., et al. Энтеральное питание в лечении острого панкреатита. Медицина: теория и практика. 2023; 8(4): 97-107.-DOI: https://doi.org/10.56871/MTP.2023.41.16.013. [Zaitov Ya.O., Kashintsev A.A., Kokhanenko N.Yu., et al. Enteral feeding in treatment of acute pancreatitis. Medicine: theory and practice. 2023; 8(4): 97-107.-DOI: https://doi.org/10.56871/MTP.2023.41.16.013 (In Rus)].

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Problems in Oncology

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).